ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

Generate Biomedicines, Inc. (GENB)

NASDAQ

$12.98

$+0.47

(+3.75%)

Generate Biomedicines, Inc. (GENB) Live Price Chart

Page last updated: 2026-03-02 18:06:00

Key Market Data

Market Cap	$1.65B
Open	$12.01
High	$15.32
Low	$11.44
Previous Close	$12.65
Price Change	$+0.47
Percentage Change	+3.75%
Volume	762K

Generate Biomedicines, Inc. (GENB) Stock Price Today

Generate Biomedicines, Inc. (GENB) is currently trading at $12.98 as of 2026-03-02 18:06:00, reflecting a +3.75% move ($+0.47) from the previous close.

In the short term, the stock has returned +260.87% over the past four weeks. Over the last 12 months, Generate Biomedicines, Inc. has recorded a +2.61% price change, indicating a stable performance relative to the broader market.

Generate Biomedicines, Inc. (GENB) 7-Day Stock Price Changes

Over the past seven days, Generate Biomedicines, Inc. has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $15.00 to the latest recorded price of $12.98, reflecting an intraday change of +3.75%. Daily movements highlight shifts in trading volume (762,291), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, GENB has delivered a +260.87% return over the past month and a +2.61% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy Generate Biomedicines, Inc. (GENB)

You can buy and trade GENB on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for GENB and Execute Your Trade

Open the trading page, enter GENB in the search bar, select the amount of GENB you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Generate Biomedicines, Inc. (GENB)?

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Generate Biomedicines, Inc. Information

Industry	--
Employees	--
Sector	--
Company Website	https://www.generatebiomedicines.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Generate Biomedicines, Inc.?

The latest trading price for Generate Biomedicines, Inc. (Common Stock) is $ 12.98, compared with a previous closing price of $ 12.65. That means the stock has moved +3.75% so far today. Intraday price updates and recent trading activity for GENB can be tracked on the live chart and quote section on this page.

2.Is Generate Biomedicines, Inc. stock going up or down?

Looking at recent performances, GENB has returned +260.87% over the past month, +2.61% over the last six months and +2.61% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for Generate Biomedicines, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does GENB currently sit relative to its 52-week high and low?

In the most recent 52-week period, Generate Biomedicines, Inc. has traded between a low of $ 11.44 and a high of $ 15.32. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether GENB is currently nearer the top or the bottom of its one-year trading band.

4.How is Generate Biomedicines, Inc. classified by sector and industry?

Generate Biomedicines, Inc. is classified in the -- sector. In practice, this means Generate Biomedicines, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing GENB’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the -- sector could influence Generate Biomedicines, Inc.’s performance.

5.Where is Generate Biomedicines, Inc. listed and how large is it by market value?

Generate Biomedicines, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 1.65B, the company is classified as a Small-cap stock. Market cap gives a quick sense of Generate Biomedicines, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does GENB's EPS tell investors about its profitability?

Trailing-twelve-month EPS of -- summarises how much profit Generate Biomedicines, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Generate Biomedicines, Inc.'s financial performance over time?

To follow Generate Biomedicines, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how GENB is performing and how the market is responding.

8.When is Generate Biomedicines, Inc. expected to report earnings?

Generate Biomedicines, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for GENB, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Generate Biomedicines, Inc.'s earnings reports?

Generate Biomedicines, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether GENB is meeting, beating or missing expectations.

10.How can I stay informed about Generate Biomedicines, Inc.'s results and guidance?

You can stay up to date on Generate Biomedicines, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for GENB on this page helps you see how new information is being reflected in the stock.

11.Does Generate Biomedicines, Inc. pay a regular cash dividend to its shareholders?

Generate Biomedicines, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor GENB's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for GENB?

Based on the latest earnings data, GENB has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Generate Biomedicines, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Generate Biomedicines, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Generate Biomedicines, Inc.?

Generate Biomedicines, Inc. is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is GENB valued in terms of P/E ratio and EPS?

Generate Biomedicines, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Generate Biomedicines, Inc.'s earnings. Comparing GENB's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Generate Biomedicines, Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

AstraZeneca PLC

AZN

Eva Live Inc.

GOAI

Ethos Technologies Inc.

LIFE

PicS N.V

PICS

Public Policy Holding Company, Inc.

PPHC

Top Gainers

Browse today's leading gainers in the US stock market

Aeries Technology, Inc.

AERT

Astrana Health Inc.

ASTH

CBL International Limited

BANL

Evolution Metals & Technologies Corp.

EMAT

MV Oil Trust

MVO

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

GENB-to-USD Calculator

Amount

GENB

USD

1 GENB = 12.98 USD